Skip to main content
Contact Us
Sign Up
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Editorial Team
About Evaluate Vantage
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
Covid-19
Covid-19 Coverage
Evaluate Vantage COVID-19 Report
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
Breadcrumb
Home
Vantage
Pharmaceutical Companies
Nabi Biopharmaceuticals
Evaluate
September 30, 2016
Upcoming events – Data from Pfizer’s staph vaccine and Agile’s contraceptive
November 11, 2011
Nabi's demise and cash could attract IPO hopefuls
October 04, 2011
Pharmasset continues to lead small cap gainers so far in 2011
July 19, 2011
NicVax failure casts shadow over Nabi's GSK partnership and nicotine vaccines
July 11, 2011
Event - Nabi’s phase III NicVax data could be decider on whether Glaxo quits
November 17, 2009
Nabi and Glaxo deal making getting to be a habit
November 05, 2009
After giving up Nabi starts again with nicotine vaccine
July 03, 2009
Chantix warnings strengthened but lack of competition will mitigate damage
October 30, 2008
Big Pharma hunting for bargains have plenty of choice
July 24, 2008
Nabi's progress with smoking vaccine should lead to deal
March 07, 2008
PDL left on the shelf
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
May 15, 2023
Pharma’s Biggest Spenders 2022 Infographic
May 03, 2023
Gene Editing: Overhyped or Unstoppable Tide?
Editor's Picks
May 16, 2023
Heightened US antitrust fears rattle biopharma
May 11, 2023
2023’s biggest launches: the story so far
May 17, 2023
Viking’s Voyage is not over yet
May 09, 2023
Gene editing: overhyped or unstoppable tide?
May 16, 2023
A slow (and low) year for FDA approvals